One of the earliest adopters was a leading pharmaceutical company, which used SpecID to rapidly identify the molecular structure of impurities in their products. By quickly pinpointing the source of these impurities, they were able to optimize their manufacturing processes and improve product quality.

Together, they poured over thousands of FTIR spectra, developing a deep understanding of the relationships between molecular structure and spectral features. They designed and tested various algorithms, evaluating their performance on diverse datasets. The team encountered numerous challenges along the way, from dealing with noisy data to addressing the variability in spectral quality.